Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Orchard Therapeutics (Sweden) AB
AB
Active
Org 5594038480
Stortorget 8, 211 34
Malmö
Research and experimental development on natural sciences and engineering
· NACE 7210
Est. 2022
1 employees
Watchlist
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Orchard Therapeutics (Sweden) AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
2M
4M
6M
8M
4M
2023
7M
2024
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2023
0M
2024
Income statement
SEK thousands
Item
2023
2024
Revenue
4 246
7 304
Staff expenses
—
—
EBITDA
196
354
Depreciation & amort.
−0
−0
EBIT
196
354
Net financials
−311
337
Profit before tax
−115
690
Tax
−0
−135
Net profit
−115
555
Balance sheet
SEK thousands
Item
2023
2024
Total assets
1 312
6 255
Equity
−90
545
Long-term debt
0
0
Short-term debt
1 402
5 710
Total debt
1 402
5 710
Financial ratios
5-year trend
EBITDA margin
4.8%
This company
15.8%
Market median
-70% vs market
2023
2024
Equity ratio
8.7%
This company
38.2%
Market median
-77% vs market
2023
2024
Return on equity
101.8%
This company
18.4%
Market median
+453% vs market
2023
2024
Net profit margin
7.6%
This company
8.1%
Market median
-6% vs market
2023
2024
Asset turnover
1.17×
This company
1.12×
Market median
+4% vs market
2023
2024
Debt / equity
10.48×
This company
0.62×
Market median
-1590% vs market
2023
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-10-01 – 2023-12-31
View
PDF
More on Orchard Therapeutics (Sweden) AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
